These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10725051)

  • 1. Introduction: public and private sector collaboration in the field of contraceptive research and development.
    Segal S
    Rev Law Soc Change; 1997; 23(3):329-37. PubMed ID: 10725051
    [No Abstract]   [Full Text] [Related]  

  • 2. Introducing new contraceptives.
    Segal SJ; Coutinho E
    Draper Fund Rep; 1986 Dec; (15):27-32. PubMed ID: 12341234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New developments also in general medicine. GSK relies on research as well as transparent collaboration with physicians (interview by Dirk Einecke, Wolfgang van den Bergh, Peter Overbeck and Cornelius Heyer)].
    Marshall CG; Strohmeyer T
    MMW Fortschr Med; 2011 May; 153(21):10-1. PubMed ID: 21739676
    [No Abstract]   [Full Text] [Related]  

  • 4. [Does the public sector have an independent research role in the development of drugs?].
    Poulsen HE; Grønlykke TB
    Ugeskr Laeger; 2003 Apr; 165(16):1674-6. PubMed ID: 12756828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avoiding pregnancy: "A plan" versus plan B.
    Rudd G
    Ann Pharmacother; 2004 Sep; 38(9):1535-6. PubMed ID: 15280516
    [No Abstract]   [Full Text] [Related]  

  • 6. Still waiting for the contraceptive revolution.
    Klitsch M
    Fam Plann Perspect; 1995; 27(6):246-53. PubMed ID: 8666089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug regulation 2056.
    Bezold C; Peck J
    Food Drug Law J; 2005; 60(2):127-36. PubMed ID: 16097091
    [No Abstract]   [Full Text] [Related]  

  • 8. Protecting consumers, prodding companies, and preventing conception: toward a model act for no fault liability for contraceptives.
    Benshoof J
    Rev Law Soc Change; 1997; 23(3):403-31. PubMed ID: 10725053
    [No Abstract]   [Full Text] [Related]  

  • 9. Public and private providers' involvement in improving their patients' contraceptive use.
    Landry DJ; Wei J; Frost JJ
    Contraception; 2008 Jul; 78(1):42-51. PubMed ID: 18555817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical sciences in 2020.
    Crommelin D; Stolk P; Besançon L; Shah V; Midha K; Leufkens H
    Nat Rev Drug Discov; 2010 Feb; 9(2):99-100. PubMed ID: 20118959
    [No Abstract]   [Full Text] [Related]  

  • 11. Realizing two-tiered innovation policy through drug regulation.
    Ridgway WE
    Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807
    [No Abstract]   [Full Text] [Related]  

  • 12. HHS ruling on Plan B introduces new risk for drugmakers.
    Willyard C
    Nat Med; 2012 Jan; 18(1):8. PubMed ID: 22227652
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contraceptive development--the view from the U.S.A. in the mid 80s].
    Potts M; Siemens A; Burton N
    Contracept Fertil Sex (Paris); 1986 Mar; 14(3):247-51. PubMed ID: 12268061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merck v. Integra: Supreme Court permits use of patented compounds to obtain Food and Drug Administration approvals.
    Manthei JR; Hathaway CR; Grant MA; Chung DD
    Food Drug Law J; 2006; 61(2):273-7. PubMed ID: 16903032
    [No Abstract]   [Full Text] [Related]  

  • 15. Implications of international drug approval systems on confidentiality of business secrets in the U.S. pharmaceutical industry.
    O'Reilly JT
    Food Drug Law J; 1998; 53(1):123-32. PubMed ID: 11795328
    [No Abstract]   [Full Text] [Related]  

  • 16. Bill 102: deal or no deal for big pharma.
    Rasky H
    Health Law Can; 2007 May; 27(4):73-84. PubMed ID: 17580795
    [No Abstract]   [Full Text] [Related]  

  • 17. Research on contraception still in the doldrums.
    Holden C
    Science; 2002 Jun; 296(5576):2172-3. PubMed ID: 12077399
    [No Abstract]   [Full Text] [Related]  

  • 18. [European drug policy: welcomed modernization but shortage of political proposals concerning industry and research].
    Alván G
    Lakartidningen; 2003 Oct; 100(44):3541-2. PubMed ID: 14651017
    [No Abstract]   [Full Text] [Related]  

  • 19. Pro-free enterprise group challenges FDA's authority to regulate drug companies' speech.
    Skolnick AA
    JAMA; 1994 Feb; 271(5):332, 335. PubMed ID: 8283568
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of the pharmaceutical industry in disseminating pharmacovigilance practice in developing countries.
    Shani S; Yahalom Z
    Food Drug Law J; 2008; 63(3):701-11. PubMed ID: 19031669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.